Robotic TAMIS procedure helps 75-year-old patient avoid rectum removal and permanent stoma, enabling faster recovery and preserving quality of life
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
The decision was driven by results from the Phase III CAPItello-281 trial,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
